Absence of Changes and Unusual Transactions. Except as described in Schedule 4.11, or except as consented to in advance in writing by the Purchaser, since the date of the Company Financial Statements:
Absence of Changes and Unusual Transactions. Except as set forth on Schedule 3.1(n), since the date of the Financial Statements:
Absence of Changes and Unusual Transactions. Except as disclosed in the Purchaser Public Documents, since August 31, 2015, none of the Purchaser or any of its Subsidiaries has transferred, assigned, sold or otherwise disposed of any of the assets shown or reflected in the Company Financial Statements or cancelled any debts or entitlements except, in each case, in the ordinary course of business.
Absence of Changes and Unusual Transactions. Except as disclosed in Section 13 of the Vendor Disclosure Letter, since the date of the Balance Sheet:
Absence of Changes and Unusual Transactions. Except as set forth in Schedule, 4.13, since April 27, 2003:
Absence of Changes and Unusual Transactions. Since the date of the Balance Sheets, except as set out in or contemplated by this Agreement:
Absence of Changes and Unusual Transactions. Except as set forth in Schedule 4.11, since the date of the Balance Sheet:
Absence of Changes and Unusual Transactions. Except as set forth on Schedule 3.02(7), since December 31, 2007, the Corporation has operated its business in all material respects in the ordinary course of business (except with respect to the transactions contemplated hereby and except for confidentiality agreements or other agreements entered into by the Corporation in the context of the sale of the Shares, the ViroChem Shares and the ESOP Shares) and has not:
Absence of Changes and Unusual Transactions. Other than as disclosed on Schedule 4.13, since the date of the Balance Sheet:
Absence of Changes and Unusual Transactions. Since January 31st, 2013 and except as disclosed in Schedule 5.5:
